home.social

#amgen — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #amgen, aggregated by home.social.

  1. #Amgen’s Dark Blue deal (up to $840m) is less about one preclinical asset and more about a trend: pharma is paying to remove proteins, not just block them. Feature: biotech.industryexaminer.com/a #Hematology #AML #Oncology #Biotech #Pharma #DrugDevelopment #ProteinDegradation #TechNews

  2. #Amgen’s Dark Blue deal (up to $840m) is less about one preclinical asset and more about a trend: pharma is paying to remove proteins, not just block them. Feature: biotech.industryexaminer.com/a #Hematology #AML #Oncology #Biotech #Pharma #DrugDevelopment #ProteinDegradation #TechNews

  3. #Amgen’s Dark Blue deal (up to $840m) is less about one preclinical asset and more about a trend: pharma is paying to remove proteins, not just block them. Feature: biotech.industryexaminer.com/a #Hematology #AML #Oncology #Biotech #Pharma #DrugDevelopment #ProteinDegradation #TechNews

  4. #Amgen’s Dark Blue deal (up to $840m) is less about one preclinical asset and more about a trend: pharma is paying to remove proteins, not just block them. Feature: biotech.industryexaminer.com/a #Hematology #AML #Oncology #Biotech #Pharma #DrugDevelopment #ProteinDegradation #TechNews

  5. Amgen CEO Bob Bradway announced that new clinical trial data show Repatha significantly reduces heart attack risk by 36% when combined with standard therapies, underscoring the importance of lowering LDL cholesterol for high-risk patients.
    #YonhapInfomax #Amgen #Repatha #HeartAttackRisk #LDLCholesterol #ClinicalTrialResults #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  6. Amgen CEO Bob Bradway announced that new clinical trial data show Repatha significantly reduces heart attack risk by 36% when combined with standard therapies, underscoring the importance of lowering LDL cholesterol for high-risk patients.
    #YonhapInfomax #Amgen #Repatha #HeartAttackRisk #LDLCholesterol #ClinicalTrialResults #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  7. Amgen CEO Bob Bradway announced that new clinical trial data show Repatha significantly reduces heart attack risk by 36% when combined with standard therapies, underscoring the importance of lowering LDL cholesterol for high-risk patients.
    #YonhapInfomax #Amgen #Repatha #HeartAttackRisk #LDLCholesterol #ClinicalTrialResults #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  8. Amgen CEO Bob Bradway announced that new clinical trial data show Repatha significantly reduces heart attack risk by 36% when combined with standard therapies, underscoring the importance of lowering LDL cholesterol for high-risk patients.
    #YonhapInfomax #Amgen #Repatha #HeartAttackRisk #LDLCholesterol #ClinicalTrialResults #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  9. Today was a historic day for Thousand Oaks as Amgen broke ground on a $600 million R&D center here. This investment, one of the largest in Ventura County history, will speed development of new medicines by putting research and process development under one roof.

    As a global biotech leader Amgen can locate anywhere – but it chose Thousand Oaks because of our world-class workforce, excellent schools, abundant open space, and safe streets.

    I’m looking forward to the scientific breakthroughs this new center will bring, right here in Thousand Oaks!

    📷 1: Alex South; 📷 3: Josh Gray

    #amgen #biotech #research #pharma #thousandoaks #venturacounty

  10. Today was a historic day for Thousand Oaks as Amgen broke ground on a $600 million R&D center here. This investment, one of the largest in Ventura County history, will speed development of new medicines by putting research and process development under one roof.

    As a global biotech leader Amgen can locate anywhere – but it chose Thousand Oaks because of our world-class workforce, excellent schools, abundant open space, and safe streets.

    I’m looking forward to the scientific breakthroughs this new center will bring, right here in Thousand Oaks!

    📷 1: Alex South; 📷 3: Josh Gray

    #amgen #biotech #research #pharma #thousandoaks #venturacounty

  11. Today was a historic day for Thousand Oaks as Amgen broke ground on a $600 million R&D center here. This investment, one of the largest in Ventura County history, will speed development of new medicines by putting research and process development under one roof.

    As a global biotech leader Amgen can locate anywhere – but it chose Thousand Oaks because of our world-class workforce, excellent schools, abundant open space, and safe streets.

    I’m looking forward to the scientific breakthroughs this new center will bring, right here in Thousand Oaks!

    📷 1: Alex South; 📷 3: Josh Gray

    #amgen #biotech #research #pharma #thousandoaks #venturacounty

  12. Today was a historic day for Thousand Oaks as Amgen broke ground on a $600 million R&D center here. This investment, one of the largest in Ventura County history, will speed development of new medicines by putting research and process development under one roof.

    As a global biotech leader Amgen can locate anywhere – but it chose Thousand Oaks because of our world-class workforce, excellent schools, abundant open space, and safe streets.

    I’m looking forward to the scientific breakthroughs this new center will bring, right here in Thousand Oaks!

    📷 1: Alex South; 📷 3: Josh Gray

    #amgen #biotech #research #pharma #thousandoaks #venturacounty

  13. Today was a historic day for Thousand Oaks as Amgen broke ground on a $600 million R&D center here. This investment, one of the largest in Ventura County history, will speed development of new medicines by putting research and process development under one roof.

    As a global biotech leader Amgen can locate anywhere – but it chose Thousand Oaks because of our world-class workforce, excellent schools, abundant open space, and safe streets.

    I’m looking forward to the scientific breakthroughs this new center will bring, right here in Thousand Oaks!

    📷 1: Alex South; 📷 3: Josh Gray

    #amgen #biotech #research #pharma #thousandoaks #venturacounty

  14. Biotech Giant Amgen Will Expand Its R&D

    Thousand Oaks-based biotech giant Amgen Inc. announced this month that it plans to invest more than $600 million in a…
    #UnitedStates #US #USA #america #Amgen #business #unitedstatesofamerica
    europesays.com/2413515/

  15. 🚀 Big news in biotech!
    Amgen is investing $600M to build a cutting-edge center for science and innovation at its global HQ in Thousand Oaks, CA—driving advancements in biotechnology and healthcare solutions. 🌱

    Meanwhile, Enveric Biosciences is relocating its HQ to Cambridge, MA, strengthening one of the world’s most dynamic biotech hubs.

    👉 Full story: dlvr.it/TMw70V

    #Biotech #Innovation #Healthcare #Amgen #EnvericBiosciences #LifeSciences #EconDev

  16. 🚀 Big news in biotech!
    Amgen is investing $600M to build a cutting-edge center for science and innovation at its global HQ in Thousand Oaks, CA—driving advancements in biotechnology and healthcare solutions. 🌱

    Meanwhile, Enveric Biosciences is relocating its HQ to Cambridge, MA, strengthening one of the world’s most dynamic biotech hubs.

    👉 Full story: dlvr.it/TMw70V

    #Biotech #Innovation #Healthcare #Amgen #EnvericBiosciences #LifeSciences #EconDev

  17. 🚀 Big news in biotech!
    Amgen is investing $600M to build a cutting-edge center for science and innovation at its global HQ in Thousand Oaks, CA—driving advancements in biotechnology and healthcare solutions. 🌱

    Meanwhile, Enveric Biosciences is relocating its HQ to Cambridge, MA, strengthening one of the world’s most dynamic biotech hubs.

    👉 Full story: dlvr.it/TMw70V

    #Biotech #Innovation #Healthcare #Amgen #EnvericBiosciences #LifeSciences #EconDev

  18. 🚀 Big news in biotech!
    Amgen is investing $600M to build a cutting-edge center for science and innovation at its global HQ in Thousand Oaks, CA—driving advancements in biotechnology and healthcare solutions. 🌱

    Meanwhile, Enveric Biosciences is relocating its HQ to Cambridge, MA, strengthening one of the world’s most dynamic biotech hubs.

    👉 Full story: dlvr.it/TMw70V

    #Biotech #Innovation #Healthcare #Amgen #EnvericBiosciences #LifeSciences #EconDev